Sort by:
ILSB 3421Senate
Physician Assistant Practice Act
Senate Floor — Calendar Order of 2nd ReadingHigh RiskScope of Practice
May 15, 2026
ILHB 4953House
Wholesale Drug Distribution — Delivery Restrictions
Senate AssignmentsMedium RiskDrug Distribution
May 15, 2026
ILSB 66Senate
Health Care Availability and Access Board Act
Senate Executive Committee — Amendments 2, 3, 4 pendingHigh RiskDrug Pricing
May 15, 2026
ILHB 4154House
Pharmacist Licensure Modernization
Senate Floor — Calendar Order of 2nd ReadingMedium RiskPharmacist Licensure
May 14, 2026
ILSB 3896Senate
Wholesale Drug Distribution Licensing Act (Senate)
House Prescription Drug Affordability Committee; Hearing 5/13Medium RiskDrug Distribution
May 14, 2026
ILHB 4793House
Pharmacist Dispensing — Non-Pharmaceutical Devices
Senate Floor — Calendar Order of 2nd ReadingLow RiskScope of Practice
May 14, 2026
ILHB 4982House
Pharmacy Practice Act — 988 Suicide & Crisis Lifeline Posting
Senate Floor — Calendar Order of 3rd Reading May 18, 2026Low RiskPharmacy Operations
May 14, 2026
NHSB 256Senate
Affordability and Safety of Clinician-Administered Drugs
Passed Senate 2026; pending in HouseHigh RiskPBM Reform
May 14, 2026
NHHB 194House
Interference with Custody; Practice of Pharmacy and Dispensing of Certain Medications
Passed House; in SenateHigh RiskPharmacy Operations
May 14, 2026
NHHB 232House
Rights of Conscience for Medical Professionals
Passed House May 2026; in SenateHigh RiskPharmacy Operations
May 14, 2026
NHHB 1423House
Synthetic and Semisynthetic Kratom Prohibition; Improper Influence
Passed House May 2026; in SenateMedium RiskControlled Substances
May 14, 2026
NHHB 1772House
Prescribing Ibogaine for Investigational Use; Physician Associate License
Passed House; in SenateHigh RiskControlled Substances
May 14, 2026
NHSB 455Senate
Health Plan Coverage of GLP-1 Medications
Passed Senate Mar 2026; in HouseHigh RiskInsurance / Coverage
May 14, 2026
NHSB 504Senate
Practice of Pharmacy and Dispensing of Certain Medications by Pharmacists
Passed Senate Mar 2026; in HouseHigh RiskScope of Practice
May 14, 2026
NHSB 557Senate
Synthetic and Semisynthetic Kratom Prohibition
Passed Senate Mar 2026; in HouseMedium RiskControlled Substances
May 14, 2026
NHSB 624Senate
Hemp-Derived Products — Access Restrictions and Criminal Adulteration
Passed Senate Mar 2026; in HouseMedium RiskHemp / Cannabis
May 14, 2026
NHSB 665Senate
PBM Managed Care Laws; Notice of Drug Pricing Options; Pharmacy Choice
Passed Senate; in HouseHigh RiskPBM Reform
May 14, 2026
OKSB 1257Senate
Uniform Controlled Dangerous Substances Act; modifying classification of certain substances
Sent to Governor 05/14/2026Medium RiskControlled Substances
May 14, 2026
OHHB 462House
Regards student use of a nasal epinephrine delivery device
Enrolled — Concurred in Senate amendments 91-0 (5/13/2026)Medium RiskPrescription Access
May 13, 2026
OKHB 4431House
Pharmacy Act; references; prescribing authority for certain persons; repealers
Enacted — Became law without signature 05/13/2026 (Senate 44-0, House 81-2)Medium RiskOmnibus / Technical
May 13, 2026
OKSB 65Senate
Substance abuse services; authorizing possession, acquisition, distribution and administration of emergency opioid antagonists and adulterant test strips by any person
Enacted — Approved by Governor 05/12/2026 (House 86-2)High RiskControlled Substances
May 13, 2026
GASB 220Senate
Putting Georgia's Patients First Act — Medical Cannabis Expansion
Enacted — Act 712 (signed May 2026)High RiskHemp / Cannabis
May 12, 2026
GAHB 506House
Medicaid Tobacco Cessation Coverage
Enacted — Act 624 (May 12, 2026)Low RiskInsurance / Coverage
May 12, 2026
GAHB 717House
Medical Practice Act; regulation of the administration of psychedelic-assisted treatment and therapy
Enacted (Act 634, signed 2026-05-12)High RiskControlled Substances
May 12, 2026
OHHB 890House
Enact Prescription Relief, Inflation Cost Elimination (PRICE) Act
House — Introduced 5/12/2026 (awaiting committee referral)High RiskDrug Pricing
May 12, 2026
OKHB 3767House
Controlled dangerous substances; adding certain substances to Schedules I and IV
Enacted — Approved by Governor 05/12/2026Low RiskControlled Substances
May 12, 2026
GASB 33Senate
Georgia Hemp Farming Act — THC Concentration Limits
Enacted — Act 461 (May 11, 2026)High RiskHemp / Cannabis
May 11, 2026
GASB 395Senate
Low THC Oil Patient Registry — Physician Reporting
Enacted — Act 506 (May 11, 2026)Medium RiskHemp / Cannabis
May 11, 2026
GAHB 1138House
Increasing Access to Contraceptives Act — Pharmacist Dispensing
Enacted — Act 447 (May 11, 2026)High RiskScope of Practice
May 11, 2026
GAHB 1275House
Stem Cell Therapy Ethical Sourcing Restrictions
Enacted — Act 453 (May 11, 2026)Medium RiskCompounding / Medical Spas
May 11, 2026
GAHB 382House
Psilocybin Schedule I Provision Revision
Enacted — Act 476 (May 11, 2026)Medium RiskControlled Substances
May 11, 2026
OKHB 4454House
Medical marijuana; providing certain restrictions on edible products
Enacted — Approved by Governor 05/07/2026Medium RiskHemp / Cannabis
May 11, 2026
NHHB 1249House
Pharmacists Providing Medical Devices Associated with Prescribed Medication
Passed House Mar 2026; in SenateMedium RiskScope of Practice
May 8, 2026
ILSB 3731Senate
First 2026 General Revisory Act
House Floor — Calendar 2nd Reading Short DebateLow RiskOmnibus / Technical
May 7, 2026
HIHB 1643House
Pharmacy Audit Framework and PBM Definition Amendment
Pending Governor (Transmitted May 7, 2026)High RiskPBM Reform
May 7, 2026
NHHB 1268House
Home Education Administration; Pharmacy Benefit Manager Provisions
Passed House May 2026; in SenateHigh RiskPBM Reform
May 7, 2026
ILSB 3223Senate
Practice of Pharmacy (FDA medication recall QR code signage)
Passed Senate; House — 2nd Reading Short Debate (5/7/2026)Low RiskPharmacy Operations
May 7, 2026
OKSB 1642Senate
Controlled dangerous substances; authorizing divided quantities for certain acute pain opioid prescriptions
Enacted — Became law without signature 05/07/2026Medium RiskControlled Substances
May 7, 2026
NHSB 400Senate
Therapeutic Cannabis Medical Oversight Board — Duties and Reporting
Passed Senate Feb 2026; in HouseLow RiskHemp / Cannabis
May 6, 2026
OKSB 444Senate
Controlled dangerous substances; modifying requirements and procedures related to destruction
Enacted — Approved by Governor 05/06/2026 (House 85-0)Medium RiskControlled Substances
May 6, 2026
OKSB 1500Senate
Pharmacy benefit managers; prohibiting certain payment conditions; provider risk; accounting requirements; AG fines
Vetoed by Governor 05/06/2026High RiskPBM Reform
May 6, 2026
AZHB 2415House
Kratom Products — Narcotic Drug Classification
Failed — Returned to House for Reconsideration; Died at Sine DieMedium RiskControlled Substances
May 5, 2026
GASB 195Senate
Pharmacist-Furnished HIV PrEP and PEP
Enacted — Act 409 (signed May 5, 2026)High RiskScope of Practice
May 5, 2026
GASB 444Senate
AI Restrictions on Private Review Agent Decisions
Enacted — Act 411 (signed May 5, 2026)High RiskInsurance / Coverage
May 5, 2026
GAHB 1329House
Schedule I Controlled Substances Update (2026)
Enacted — Act 390 (May 5, 2026)High RiskControlled Substances
May 5, 2026
NHHB 1809House
Medical Psilocybin Advisory Board
Passed House Mar 2026; in SenateMedium RiskControlled Substances
May 5, 2026
OKSB 1344Senate
Insulin Access and Affordability Program
Enacted — Approved by Governor 05/01/2026 (House 68-22)High RiskDrug Pricing
May 5, 2026
OKSB 2007Senate
Pharmacy Benefit Managers; requiring PBM to remit certain fees
Vetoed by Governor 05/01/2026Medium RiskPBM Reform
May 5, 2026
OKHB 2941House
Fentanyl overdose and overdose reporting; first responders; report; immunity; prohibited acts
Enacted — Approved by Governor 05/01/2026Medium RiskControlled Substances
May 4, 2026
HISB 3199Senate
Mental Health Emerging Therapies Task Force (Psilocybin and MDMA)
Failed — Conference Committee Impasse May 1, 2026Medium RiskControlled Substances
May 1, 2026
ILHB 5148House
Controlled Substances — PMP Schedule II & IV
Senate Floor — Calendar Order of 3rd ReadingMedium RiskControlled Substances
Apr 30, 2026
OHHB 835House
Ohio Medical Aid in Dying (MAID) Act
House Health CommitteeMedium RiskScope of Practice
Apr 30, 2026
AZSB 1178Senate
Naturopathic physicians; drug administration
Passed Senate 17-12; House COW Do Pass Amended 4/28 — awaiting House 3rd ReadingMedium RiskScope of Practice
Apr 28, 2026
OKHB 4457House
Pharmacy benefits managers; terms; prohibiting certain acts; enforcement by Attorney General
Senate General Order (placed 4/28/2026; passed Business & Insurance 4/23)High RiskPBM Reform
Apr 28, 2026
ILSB 3801Senate
Prescription Labeling (Senate)
Re-referred to Assignments (Rule 3-9(a)) — Effectively DeadLow RiskPrescription Labeling
Apr 24, 2026
ILSB 3521Senate
Controlled Substances — Prescriber/Dispenser System (Senate)
Re-referred to Assignments (Rule 3-9(a)) — Effectively DeadLow RiskControlled Substances
Apr 24, 2026
NHSB 465Senate
Classifying Xylazine as Schedule III Controlled Drug
Passed Senate Mar 2026; in HouseHigh RiskControlled Substances
Apr 23, 2026
OKSB 2074Senate
Pharmacy benefit managers; prohibiting PBM from refusing to accept documentation; appeal requirements
Vetoed by Governor 04/22/2026Medium RiskPBM Reform
Apr 22, 2026
OKHB 3127House
Medical marijuana; policy for applicants and employees; exceptions
Enacted — Approved by Governor 04/17/2026Low RiskHemp / Cannabis
Apr 20, 2026
ILHB 1443House
Prescription Drug Affordability Board
Re-referred to Rules (Rule 19(a)) — Effectively DeadHigh RiskDrug Pricing
Apr 17, 2026
ILHB 5046House
Electronic Prescription Transfers
Re-referred to Rules (Rule 19(a)) — Effectively DeadLow RiskElectronic Prescribing
Apr 17, 2026
ILHB 5427House
Wholesale Drug Distribution Licensing Act
Re-referred to Rules (Rule 19(a)) — Effectively DeadMedium RiskDrug Distribution
Apr 17, 2026
ILHB 4243House
Retail Pharmacy On-Site Requirements
Re-referred to Rules (Rule 19(a)) — Effectively DeadHigh RiskPharmacy Operations
Apr 17, 2026
ILSB 3507Senate
Controlled Substances — PMP Schedule II & IV (Senate)
Re-referred to Assignments (Rule 3-9(a)) — Effectively DeadMedium RiskControlled Substances
Apr 17, 2026
AZSB 1188Senate
Approved Medications — Scheduling and Prescription Authority
House Committee of the Whole DP 4/16; No 3rd Reading Before Sine DieMedium RiskControlled Substances
Apr 16, 2026
AZSB 1494Senate
Health insurance; patient steering; prohibition
Passed Senate 16-13; House COW Do Pass 4/16 — awaiting House 3rd ReadingHigh RiskPBM Reform
Apr 16, 2026
KYSB 56Senate
Nonopioid Analgesics — Medicaid Utilization Controls
Died — Senate Did Not Concur in House Floor AmendmentsHigh RiskPBM Reform
Apr 15, 2026
KYHB 2House
Medicaid Reform
Enacted (Acts Ch. 179) — Veto Override Apr 14High RiskInsurance / Coverage
Apr 14, 2026
KYSB 65Senate
Deficient Administrative Regulations (Pharmacy/KASPER)
Enacted (Acts Ch. 156) — Veto Override Apr 14High RiskPharmacy Operations
Apr 14, 2026
KYSB 77Senate
Ibogaine Research for Opioid Use Disorder
Enacted (Acts Ch. 158) — Veto Override Apr 14Low RiskControlled Substances
Apr 14, 2026
KYHB 387House
Veterinary Controlled Substances Prescribing Council
Enacted (Acts Ch. 170) — Veto Override Apr 14, Emergency ClauseMedium RiskControlled Substances
Apr 14, 2026
KYHB 676House
Statewide Health Data Utility Study
Enacted (Acts Ch. 150) — Became Law Without SignatureMedium RiskPharmacy Operations
Apr 14, 2026
AZHB 2660House
Health Boards — Licensure Decisions and Investigation
Passed Both Chambers 4/14; Pending Governor (Moratorium)High RiskPharmacy Operations
Apr 14, 2026
KYSB 116Senate
Physician Assistant Prescribing Authority
Enacted (Acts Ch. 94, Signed Apr 10, 2026)High RiskScope of Practice
Apr 10, 2026
KYHB 280House
Health Care — APRN & School Medication Access
Enacted (Acts Ch. 75, Signed Apr 10, 2026)Medium RiskScope of Practice
Apr 10, 2026
HISCR 59Senate
Emergency Out-of-State Healthcare Licensure Procedures
Senate PSM Passed with Amendments Apr 6, 2026; Engrossed Apr 9Low RiskPharmacist Licensure
Apr 9, 2026
KYHB 388House
Prescription Drugs — Controlled Substances & KASPER
Enacted (Acts Ch. 38, Signed Apr 7, 2026)High RiskControlled Substances
Apr 7, 2026
AZSB 1713Senate
AHCCCS — Procurement and Contracting
House S/E DPA 4/1; Senate Floor Pending ConcurrenceMedium RiskInsurance / Coverage
Apr 1, 2026
AZHB 2732House
Pharmacy Board — Continuation
Failed — Stalled in Senate; Died at Sine DieHigh RiskOmnibus / Technical
Apr 1, 2026
OKHB 3538House
Pharmacy benefits managers; definitions; contractual duties to provider; prohibitions; reimbursement amounts
Senate Health & Human Services (referred 4/1/2026 after House passage)High RiskPBM Reform
Apr 1, 2026
OKHB 4124House
Ivermectin; defining term; allowing ivermectin to be sold or purchased without prescription; immunity for pharmacy
Senate Health & Human Services (referred 4/1/2026 after House passage)Medium RiskPrescription Access
Apr 1, 2026
OHHB 229House
PBM Licensing and Contract Requirements
Enacted (Signed Mar 31, 2026)High RiskPBM Reform
Mar 31, 2026
GAHB 419House
Opioid Antagonists in University System of Georgia
Senate Tabled (Mar 31, 2026) — Passed HouseMedium RiskControlled Substances
Mar 31, 2026
GASR 927Senate
Senate Study Committee on PBMs and Consumer Drug Access
Senate Passed/Adopted (Mar 31, 2026)Medium RiskPBM Reform
Mar 31, 2026
GAHB 1393House
Hospitals; allow rural hospitals to join together to allow further purchasing power with third-party payors but retain their independence
Passed House; Senate Tabled 3/31/2026Medium Risk340B Program
Mar 31, 2026
ILHB 1272House
Wholesale Prescription Drug Importation Program Act
Re-referred to Rules Committee (Rule 19(a))Medium RiskDrug Importation
Mar 27, 2026
ILHB 5116House
Controlled Substances Act — Prescriber/Dispenser System
Re-referred to Rules (Rule 19(a)) — Effectively DeadLow RiskControlled Substances
Mar 27, 2026
ILSB 3146Senate
340B Drug Pricing Program Reporting Act
Re-referred to Assignments (Rule 3-9(a)) — Effectively DeadMedium Risk340B Program
Mar 27, 2026
ILHB 4065House
340B Grantee Contract Pharmacy Access Act
Re-referred to Rules Committee (Rule 19(a))Medium Risk340B Program
Mar 27, 2026
ILHB 4954House
340B Drug Pricing Program Reporting Act (House)
Re-referred to Rules Committee (Rule 19(a))Low Risk340B Program
Mar 27, 2026
ILHB 4761House
Pharmacy Benefit Reimbursement (NADAC floor + $10.49 dispensing fee)
House — Re-referred to Rules Committee (3/27/2026)High RiskPBM Reform
Mar 27, 2026
ILSB 3764Senate
Controlled Substances — Schedule II 90-Day Supply
Postponed in Licensed Activities CommitteeMedium RiskControlled Substances
Mar 25, 2026
AZHB 2364House
Abortion-Inducing Drugs — Mail/Delivery Violations
Failed — Held in Senate Judiciary 3/25; Died at Sine DieHigh RiskControlled Substances
Mar 25, 2026
AZHB 2434House
Controlled Substances Prescription Monitoring Program (CSPMP)
Senate HHS Do Pass 3/25; No Floor Action Before Sine DieHigh RiskPDMP
Mar 25, 2026
OHHB 220House
Health Insurance and Medicaid Prior Authorization Reform
Passed House 84-11; Senate FIIT CommitteeHigh RiskInsurance / Coverage
Mar 25, 2026
OHHB 780House
Enact the Medicaid Savings Act
House — Medicaid Committee (3/25/2026)High RiskPBM Reform
Mar 25, 2026
OHHB 783House
Chemical Abortion Reversal Notice
House Health CommitteeMedium RiskPrescription Access
Mar 24, 2026
AZSB 1458Senate
Pharmacy Board — Civil Penalties and PBM Steering
Passed Senate 29-1; House Rules with S/E (Did Not Reach Gov)High RiskPharmacy Operations
Mar 23, 2026
AZHB 2697House
Expired Opioid Antagonists — Use and Dispensing
Failed — Did Not Progress Past Senate RAGE; Died at Sine DieMedium RiskControlled Substances
Mar 23, 2026
AZHB 2733House
Pharmacy Board — Renewals and Ownership Change
Failed — Stalled in Senate HHS; Died at Sine DieHigh RiskPharmacy Operations
Mar 23, 2026
GAHR 1794House
Commissioner of Insurance; conduct a comprehensive review of prescription drug pricing
House — Special Rules Committee (2nd Readers 3/23/2026)Low RiskDrug Pricing
Mar 23, 2026
AZSB 1710Senate
Pharmacy Benefits — Patient Steering Prohibition
Failed — Died at Sine Die; Provisions Grafted into SB 1458High RiskPBM Reform
Mar 20, 2026
AZHB 2444House
Pharmacists — Independent Testing and Treatment (Carryover)
Senate Returned for Reconsideration; House COW DPA — Dead at Sine DieHigh RiskScope of Practice
Mar 17, 2026
AZHB 2953House
Pharmacy Board — Civil Penalties
Failed — Stalled in Senate RAGE; Died at Sine DieHigh RiskPharmacy Operations
Mar 16, 2026
AZSB 1545Senate
PBM Pharmacy Ownership Prohibition
Failed — Died in Committee at Sine DieHigh RiskPBM Reform
Mar 15, 2026
HISB 1613Senate
Adult-Use Cannabis Legalization
Failed — Failed to Advance from House Committees in 2026Low RiskHemp / Cannabis
Mar 15, 2026
INHB 1277House
Long Term Care / Medicaid PathWays Reform
Enacted (Public Law 160, HEA 1277, Signed Mar 12, 2026)Medium RiskLong-Term Care
Mar 12, 2026
NHSB 478Senate
Prescription Drug Affordability and PBM Accountability
In Senate CommerceHigh RiskPBM Reform
Mar 12, 2026
OHSB 230Senate
Pharmacist Test and Treat for Respiratory Conditions
Senate Health Committee — Multiple Proponent HearingsHigh RiskScope of Practice
Mar 11, 2026
NHHB 1638House
Bypass Mechanism for Step Therapy Protocols When Medically Necessary
In House Commerce and Consumer AffairsMedium RiskInsurance / Coverage
Mar 11, 2026
KYHB 895House
AN ACT relating to the regulation of psychoactive substances
House — Licensing, Occupations & Administrative Regulations (3/11/2026)Medium RiskHemp / Cannabis
Mar 11, 2026
KYHB 896House
AN ACT relating to hemp products and declaring an emergency
House — Licensing, Occupations & Administrative Regulations (3/11/2026)Medium RiskHemp / Cannabis
Mar 11, 2026
HISB 2047Senate
PBM Maximum Allowable Cost Lists and Appeals
Senate Engrossed Mar 10, 2026 — Insurance Commissioner EnforcementHigh RiskPBM Reform
Mar 10, 2026
INSB 91Senate
Syringe Exchange Program Extension
Enacted (Public Law 144, SEA 91, Became Law Without Governor Signature Mar 9, 2026)Medium RiskControlled Substances
Mar 9, 2026
GAHR 948House
House Study Committee on PBMs and Consumer Drug Access
House Passed/Adopted By Substitute (Mar 9, 2026)Medium RiskPBM Reform
Mar 9, 2026
GAHB 810House
Pharmacy Reimbursement Floor (NADAC + Dispensing Fee)
House Committee Favorably Reported By Substitute (Mar 6, 2026)High RiskPBM Reform
Mar 6, 2026
GAHB 968House
Mitragynine & 7-OH (Kratom) Schedule I
House Committee Favorably Reported By Substitute (Mar 6, 2026)High RiskControlled Substances
Mar 6, 2026
GAHB 1089House
Ivermectin as Over-the-Counter Medication
House Committee Favorably Reported By Substitute (Mar 6, 2026)Medium RiskPrescription Access
Mar 6, 2026
NHSB 547Senate
PBM Practices — Regulation and Transparency
In Senate CommerceHigh RiskPBM Reform
Mar 6, 2026
INSB 293Senate
Pharmacist Licensing Requirements
Enacted (Public Law 140)Medium RiskPharmacist Licensure
Mar 5, 2026
INSB 282Senate
Medical Spas and Drug Compounding Oversight
Enacted (Public Law 136, SEA 282, Signed Mar 5, 2026)High RiskCompounding / Medical Spas
Mar 5, 2026
INSB 262Senate
INSPECT Program (Prescription Drug Monitoring)
Enacted (SEA 262, Signed Mar 5, 2026)Medium RiskPDMP
Mar 5, 2026
INSB 189Senate
Nonparticipating Providers — Out-of-Network Penalties
Enacted (Public Law 119, SEA 189, Signed Mar 5, 2026)Medium RiskInsurance / Coverage
Mar 5, 2026
INSB 144Senate
Tobacco, E-Liquid, and Vapor Devices
Enacted (Public Law 141, SEA 144, Signed Mar 5, 2026)Low RiskControlled Substances
Mar 5, 2026
KYSB 38Senate
Reimbursements for Pharmacist Services
Died in House Banking & Insurance at Sine DieHigh RiskPrescription Access
Mar 5, 2026
KYHB 584House
Licensure Ban Removal for Controlled Substance Felons
Died in Senate Committee on Committees at Sine DieMedium RiskPharmacist Licensure
Mar 5, 2026
NHSB 477Senate
Transparency in the 340B Drug Pricing Program
In Senate Health and Human ServicesMedium Risk340B Program
Mar 5, 2026
INHB 1271House
Payment of Health Claims — Downcoding Prohibition
Enacted (Public Law 88, HEA 1271, Signed Mar 4, 2026)Medium RiskInsurance / Coverage
Mar 4, 2026
KYHB 750House
Cychlorphine — New Controlled Substance
Died in House Judiciary Committee at Sine DieLow RiskControlled Substances
Mar 4, 2026
KYHB 729House
Jimmie's Law — Pharmaceutical Drug Safety
Died in House L&O&AR Committee at Sine DieHigh RiskCompounding / Medical Spas
Mar 4, 2026
KYHB 735House
Regulation of Pharmacists — Technical Correction
Died in House L&O&AR Committee at Sine DieLow RiskOmnibus / Technical
Mar 4, 2026
INHB 1114House
Coverage for Advanced Metastatic Cancer Prescriptions
Enacted (Public Law 52, HEA 1114, Signed Mar 3, 2026)Medium RiskInsurance / Coverage
Mar 3, 2026
GAHB 1309House
Dispensing Practitioners Compliance with Pharmacy Practice Act
House Committee Favorably Reported By Substitute (Mar 3, 2026)High RiskPharmacy Operations
Mar 3, 2026
GAHB 1332House
Georgia Buy American Medicine Act
House Committee Favorably Reported By Substitute (Mar 3, 2026)Medium RiskDrug Distribution
Mar 3, 2026
OHSB 434Senate
Verified Opioid and Intoxicant Consumer Ed (VOICE) Act
Senate Health CommitteeMedium RiskControlled Substances
Mar 1, 2026
GASB 602Senate
Prior Authorization & Utilization Review Reform (Major)
Senate Insurance and Labor — Read and Referred (Feb 26, 2026)Medium RiskInsurance / Coverage
Feb 26, 2026
KYHB 680House
AN ACT relating to controlled substances
House — Judiciary (2/26/2026)Medium RiskControlled Substances
Feb 26, 2026
KYSB 253Senate
Medicinal Cannabis — KASPER Integration
Died in Senate Committee on Committees at Sine DieMedium RiskHemp / Cannabis
Feb 25, 2026
OKHB 1484House
Rain's Law; instruction on fentanyl abuse prevention and drug poisoning awareness
Enacted — Approved by Governor 02/25/2026Low RiskControlled Substances
Feb 25, 2026
INSB 250Senate
Regulation of Hemp
Passed Senate; Died on House CalendarHigh RiskHemp / Cannabis
Feb 24, 2026
GAHB 326House
State Health Benefit Plan Nonopioid Coverage Parity Act
House Committee Favorably Reported By Substitute (Feb 24, 2026)Medium RiskInsurance / Coverage
Feb 24, 2026
KYHB 646House
Pharmaceuticals to Intentionally Terminate Life
Died in House Judiciary Committee at Sine DieHigh RiskControlled Substances
Feb 23, 2026
GAHB 1361House
Pharmacy Compounding of Active Pharmaceutical Ingredients
House Health — Second Readers (Feb 20, 2026)High RiskCompounding / Medical Spas
Feb 20, 2026
KYSB 211Senate
Generic Drug and Biosimilar Coverage
Died in Senate Committee on Committees at Sine DieMedium RiskDrug Pricing
Feb 19, 2026
HISB 1279Senate
340B Telepharmacy Supervision
Died — Carryover to 2026 Failed to Advance from CommitteeMedium RiskDrug Distribution
Feb 19, 2026
HIHB 223House
Daniel K. Inouye College of Pharmacy Special Fund
Carryover from 2025; HD1 Stalled — Superseded by HB 2161 in 2026Low RiskPharmacist Licensure
Feb 19, 2026
HIHB 2161House
Daniel K. Inouye College of Pharmacy Special Fund (2026 Refile)
House Finance Committee — CPC Adopted HPhA Fee StructureMedium RiskPharmacist Licensure
Feb 19, 2026
HISB 2208Senate
State Pharmacy Benefit Manager — Med-QUEST
Senate — Tracked by Board of PharmacyHigh RiskPBM Reform
Feb 19, 2026
HISB 1509Senate
Prescription Drug Rebate Pass-Through — PBM Study
HD1 Converted to LRB Study — Carryover After House CPC DeferralMedium RiskPBM Reform
Feb 19, 2026
HIHB 1539House
Repeal of Community vs. Mail-Order Pharmacy Parity Prohibition (House Companion)
Failed — No Committee Hearing HeldLow RiskPharmacy Operations
Feb 19, 2026
HIHB 1767House
Opioid Antagonist Coverage Mandate
In Committee — Tracked by Board of PharmacyMedium RiskInsurance / Coverage
Feb 19, 2026
HISB 480Senate
340B Contract Pharmacy Access (Senate Companion to HB 712)
Carryover — Functionally Superseded by Enacted HB 712Low Risk340B Program
Feb 19, 2026
HISB 874Senate
Veterinary Prescription Portability — Pharmacy Dispensing
Carryover from 2025Medium RiskPrescription Access
Feb 19, 2026
HISB 956Senate
Telehealth Opioid Prescribing — Three-Day Supply Exception
Carryover from 2025Medium RiskControlled Substances
Feb 19, 2026
HISB 2038Senate
Confidential Abortion Medication Labeling
Failed — Deferred by Senate HHSMedium RiskPrescription Labeling
Feb 19, 2026
HIHB 216House
Step Therapy Protocol Standards
Carryover — Companion SB 226 in SenateMedium RiskInsurance / Coverage
Feb 19, 2026
HIHB 1648House
Workers Compensation — OTC Drug Dispensing Prohibition
In Committee — Tracked by Board of PharmacyMedium RiskDrug Distribution
Feb 19, 2026
AZSB 1542Senate
Controlled Substances — MDMA Research and Access
Failed — Senate Public Safety DP 2/18; Died at Sine DieMedium RiskControlled Substances
Feb 18, 2026
ILHB 2371House
340B Contract Pharmacy Protections
House Concurrence Calendar — Senate Amends 1, 2High Risk340B Program
Feb 17, 2026
KYSB 72Senate
Health Care Heroes Act — Conscience Protections
Died in House Committee on Committees at Sine DieHigh RiskPrescription Access
Feb 17, 2026
AZHB 2196House
Pharmacists — Reimbursement Costs and Appeals
Failed — Stalled in House Appropriations; Died at Sine DieHigh RiskPBM Reform
Feb 16, 2026
AZHB 4036House
Bulk Drug Substances — GLP-1 Compounding Prohibitions
Failed — Withdrawn from Committee; Died at Sine DieHigh RiskCompounding / Medical Spas
Feb 13, 2026
OHSB 309Senate
Abortion Pill Provider Liability Education (APPLE) Act
Senate Health CommitteeHigh RiskPrescription Access
Feb 13, 2026
HISB 2283Senate
Repeal of Community vs. Mail-Order Pharmacy Parity Prohibition
Failed — Deferred by Senate HHS Feb 13, 2026Medium RiskPharmacy Operations
Feb 13, 2026
NHHB 1755House
340B Discounted Drug Purchasing Program
In committeeMedium Risk340B Program
Feb 12, 2026
AZHB 4124House
Health insurance; pharmacy; reimbursement rates
House — Held in Health & Human Services (2nd reading 2/12)Medium RiskPBM Reform
Feb 12, 2026
AZHB 4047House
Medical Spas — Licensure and Regulation
Failed — Died at House 2nd Read at Sine DieHigh RiskCompounding / Medical Spas
Feb 11, 2026
OHHB 324House
Patient Protection Act — Severe-Adverse-Effect Drug Prescribing
Passed House 59-28; Senate Health CommitteeHigh RiskPrescription Access
Feb 11, 2026
ILHB 5327House
Prescription Labeling
Referred to Rules CommitteeLow RiskPrescription Labeling
Feb 10, 2026
KYSB 174Senate
Pharmacy Technician Supervision (Nonretail)
Died in Senate Committee on Committees at Sine DieMedium RiskPharmacy Operations
Feb 10, 2026
AZSB 1716Senate
Clozapine; access; monitoring modifications
Senate — Referred to Appropriations, Transportation and Technology (2nd reading 2/9)Medium RiskPrescription Access
Feb 9, 2026
AZHB 2965House
Covered Entities — 340B Drug Distribution
Failed — Died at House 2nd Read at Sine DieHigh Risk340B Program
Feb 5, 2026
GAHB 1119House
Workers' Compensation Pharmacy Care Networks
House Withdrawn, Recommitted (Feb 5, 2026)Medium RiskPharmacy Operations
Feb 5, 2026
ILHB 4655House
Pharmacy — Refusal to Dispense
Referred to Rules CommitteeMedium RiskPharmacy Operations
Feb 3, 2026
GASB 450Senate
Opioid Antagonists in Public Libraries
Senate State and Local Governmental Operations — Read and Referred (Feb 3, 2026)Low RiskControlled Substances
Feb 3, 2026
OKSB 1431Senate
Practice of pharmacy; authorizing dispensing of self-administered hormonal contraceptives under certain conditions
Senate Health & Human Services (referred 2/3/2026)Low RiskScope of Practice
Feb 3, 2026
INSB 236Senate
Abortion inducing drugs and abortion reports
Passed Senate 35-10; House — Referred to Public Health (1/29/2026)High RiskPrescription Access
Jan 29, 2026
INSB 157Senate
Generic Drug Cost Disclosure
Passed Senate; Died in House CommitteeMedium RiskDrug Pricing
Jan 28, 2026
AZSB 1309Senate
Pharmacists — Care Standard and Prescriptions
Failed — Died at Senate 2nd Read at Sine DieHigh RiskScope of Practice
Jan 28, 2026
GAHB 1006House
Opioid Antagonist in First Aid Kits
House Public and Community Health — Second Readers (Jan 28, 2026)Low RiskControlled Substances
Jan 28, 2026
KYHB 431House
AN ACT relating to opioid antagonists
House — Health Services (1/28/2026)Low RiskControlled Substances
Jan 28, 2026
GAHB 981House
APRN/PA Prescriptive Authority Expansion
House Public and Community Health — Second Readers (Jan 27, 2026)Medium RiskScope of Practice
Jan 27, 2026
KYSB 128Senate
AN ACT relating to prescription drugs
Senate — Committee on Committees (1/27/2026)High RiskPBM Reform
Jan 27, 2026
AZHB 2569House
Terminally Ill Individuals — End-of-Life Decisions (Thomas M. Dow Act)
Failed — Died at House 2nd Read at Sine DieHigh RiskScope of Practice
Jan 21, 2026
AZHB 2653House
Abortion Repeals
Failed — Died at House 2nd Read at Sine DieMedium RiskScope of Practice
Jan 21, 2026
AZSB 1218Senate
Abortion Repeals (Senate)
Failed — Died at Senate 2nd Read at Sine DieMedium RiskScope of Practice
Jan 21, 2026
AZHB 2530House
Abortion; providers; waiting period; ultrasound
House — Referred to Health & Human Services (2nd reading 1/21)Medium RiskPrescription Access
Jan 21, 2026
KYSB 103Senate
Prescription Drug Cost-Sharing Limits
Died in Senate Committee on Committees at Sine DieHigh RiskDrug Pricing
Jan 16, 2026
INSB 173Senate
Health care matters
Senate — Reassigned to Appropriations after amend-do-pass (1/15/2026)Medium RiskInsurance / Coverage
Jan 15, 2026
KYHB 153House
Medications for Substance Use Disorder
Died in House Health Services Committee at Sine DieMedium RiskControlled Substances
Jan 14, 2026
KYSB 82Senate
Medications for Substance Use Disorder (Senate)
Died in Senate Committee on Committees at Sine DieMedium RiskControlled Substances
Jan 13, 2026
AZHB 2007House
Ivermectin — Over-the-Counter Drug
Failed — Died at House 2nd Read at Sine DieMedium RiskPrescription Access
Jan 13, 2026
GAHB 931House
Georgia Prescription Drug Affordability Board
House Health — Second Readers (Jan 12, 2026)High RiskDrug Pricing
Jan 12, 2026
GAHB 923House
Pharmacy Written Patient Information Mandate
House Health — Second Readers (Jan 12, 2026)Medium RiskPrescription Labeling
Jan 12, 2026
GAHB 897House
Urgent Insulin Safety Net Program
House Public and Community Health — Second Readers (Jan 12, 2026)Medium RiskPrescription Access
Jan 12, 2026
GAHB 898House
Continuing Insulin Safety Net Act
House — Public and Community Health Committee (2nd Readers 1/12/2026)Medium RiskPrescription Access
Jan 12, 2026
INSB 221Senate
Pharmacist Treatment by Standing Order
Referred to Committee (Session Adjourned)Medium RiskScope of Practice
Jan 8, 2026
INHB 1399House
Ephedrine and Pseudoephedrine Products
Referred to Committee (Session Adjourned)Low RiskControlled Substances
Jan 8, 2026
INHB 1405House
Prescription drug assistance program for the elderly
House — Referred to Public Health (1/8/2026)Medium RiskPrescription Access
Jan 8, 2026
NHSB 247Senate
Prohibiting PBM Network Exclusion for Pharmacies Refusing Below-Cost Reimbursement
Passed Senate Mar 2025; rereferred and pending in 2026High RiskPBM Reform
Jan 7, 2026
NHHB 570House
Repealing the Prescription Drug Affordability Board
In committee — rereferred for 2026High RiskDrug Pricing
Jan 7, 2026
NHHB 648House
Insurance Coverage for Continuous Glucose Monitoring
Rereferred to committee for 2026Medium RiskInsurance / Coverage
Jan 7, 2026
INHB 1129House
Advanced Practice Registered Nurses
Referred to Committee (Session Adjourned)High RiskScope of Practice
Jan 5, 2026
OHSB 56Senate
Marijuana and Intoxicating Hemp Regulation
Enacted (Signed Dec 19, 2025; Effective Mar 20, 2026)High RiskHemp / Cannabis
Dec 19, 2025
OHHB 629House
Pharmacist Prescribing Authority Act (Test and Treat)
House Health CommitteeHigh RiskScope of Practice
Dec 11, 2025
HIHB 866House
Mifepristone Stockpile — Department of Health
Carryover to 2026 Regular Session; No Further ActionMedium RiskPrescription Access
Dec 8, 2025
HISB 463Senate
Hawaii Kratom Consumer Protection Act
Failed — Stalled in Senate Feb 2025; Companion HB 717 Carried Over and DiedLow RiskControlled Substances
Dec 8, 2025
HIHB 954House
Relating to Prior Authorization
Carried over to 2026 — House Health CommitteeHigh RiskInsurance / Coverage
Dec 8, 2025
HISB 1519Senate
Relating to Prior Authorization
Carried over to 2026 — Senate Commerce and Consumer ProtectionHigh RiskInsurance / Coverage
Dec 8, 2025
HISB 957Senate
Relating to Overdose Prevention
Carried over to 2026 — Senate Ways and MeansMedium RiskControlled Substances
Dec 8, 2025
ILHB 0767House
Regulation — Tech (Public Health, Pharmacy, and Public Aid Code amendments)
Enacted (Public Act 104-0439, signed 2025-12-02)Medium RiskOmnibus / Technical
Dec 2, 2025
INHB 1011House
End of life options (Medical Aid in Dying)
House — Referred to Public Health (Prefiled 12/1/2025)High RiskPrescription Access
Dec 1, 2025
OHHB 88House
Fentanyl Trafficking and Drug Penalties
Passed House; Senate CommitteeMedium RiskControlled Substances
Nov 25, 2025
OHHB 253House
License advanced practice respiratory therapists
Passed House 96-0 (11/12/2025); Senate Health CommitteeHigh RiskScope of Practice
Nov 19, 2025
OHHB 276House
340B Covered Entity Reimbursement Protections
House Insurance CommitteeHigh Risk340B Program
Nov 12, 2025
OHHB 587House
Kratom Product Sales Regulation (House Companion)
House Agriculture CommitteeMedium RiskControlled Substances
Nov 12, 2025
OHSB 299Senate
Kratom Product Sales Regulation
Senate General Government CommitteeMedium RiskControlled Substances
Nov 7, 2025
OHHB 448House
Apply Prescription Drug Rebates to Cost-Sharing
House Insurance CommitteeMedium RiskInsurance / Coverage
Oct 8, 2025
OHHB 449House
Better Access to Health Care Act (APRN Practice)
House Health CommitteeMedium RiskScope of Practice
Oct 8, 2025
OHHB 192House
Community Pharmacy Protection Act
House Insurance CommitteeMedium RiskPBM Reform
Oct 7, 2025
OHSB 198Senate
340B Covered Entity Reimbursement Protections (Senate Companion)
Senate Health CommitteeMedium Risk340B Program
Oct 1, 2025
OHSB 249Senate
OTC Ivermectin Dispensing
Senate Health CommitteeMedium RiskPrescription Access
Oct 1, 2025
TXHB 7House
Relating to prohibitions on the manufacture and provision of abortion-inducing drugs, including the jurisdiction of and effect of certain judgments by courts within and outside this state with respect to the manufacture and provision of those drugs, and to protections from certain counteractions under the laws of other states and jurisdictions; authorizing qui tam actions.
Enacted (2nd Called Session) — Signed by Gov. Abbott; effective 12/04/2025High RiskControlled Substances
Sep 17, 2025
TXHB 25House
Relating to a pharmacist's authority to dispense ivermectin without a prescription.
Enacted (2nd Called Session) — Signed by Gov. Abbott; effective 12/04/2025High RiskPharmacist Licensure
Sep 17, 2025
OHSB 258Senate
Better Access to Health Care Act (APRN Practice, Senate)
Senate Health CommitteeMedium RiskScope of Practice
Sep 9, 2025
OHSB 227Senate
Insulin Cost-Sharing Cap (Senate Companion)
Senate Financial Institutions, Insurance and TechnologyLow RiskDrug Pricing
Sep 3, 2025
NHHB 701House
Relative to the terminal patients' right to try act
Enacted (Chapter 304, signed by Gov. Ayotte 2025-08-20; effective 2026-01-01)Medium RiskPrescription Access
Aug 25, 2025
TXSB 6Senate
Relating to the regulation of certain products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids contained in those products.
In House Public Health (referred 08/20/2025) — 2nd Called Session retry of vetoed SB 3High RiskHemp / Cannabis
Aug 20, 2025
OHHB 374House
Prescription Drug Readers for Visually Impaired Patients
House Insurance CommitteeLow RiskPrescription Labeling
Aug 19, 2025
TXHB 227House
Relating to adding certain substances to the Texas Controlled Substances Act and regulating kratom and tianeptine.
No Action — Filed 08/18/2025 (89th 2nd Called Session); did not receive a hearingLow RiskControlled Substances
Aug 18, 2025
TXHB 6House
Relating to the regulation of certain products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids contained in those products.
In House Public Health (referred 08/18/2025) — 2nd Called Session retry of vetoed SB 3High RiskHemp / Cannabis
Aug 18, 2025
ILHB 3489House
Pharmacists — Contraceptives
Enacted (Public Act 104-0312, signed 2025-08-15; effective 2026-01-01)High RiskScope of Practice
Aug 15, 2025
NHHB 117House
Substitution of Biological Products
Enacted — Chapter 163 (signed Jul 15, 2025; eff. Sep 13, 2025)High RiskPharmacy Operations
Jul 22, 2025
NHHB 473House
Criminalizing Exposure of Children to Controlled Substances
Enacted (signed by Governor Ayotte 2025)High RiskControlled Substances
Jul 22, 2025
NHHB 677House
Epinephrine at Recreation Camps, Schools, and Higher Education Institutions
Enacted (passed both chambers 2025)Medium RiskPrescription Access
Jul 22, 2025
NHSB 61Senate
Prescriptions for State Prisoners Paid by Department of Corrections
Enacted (signed 2025)Medium RiskInsurance / Coverage
Jul 22, 2025
NHSB 80Senate
Consolidated Licensing of Wholesale and Retail E-Cigarette Sellers
Enacted (signed 2025)Low RiskPharmacy Operations
Jul 22, 2025
NHSB 58Senate
Venue for Drug Distribution Causing Death; Surrogate Parent Background Checks
Enacted (signed Jul 2025)High RiskControlled Substances
Jul 3, 2025
HIHB 1482House
Relating to Controlled Substances
Enacted (Act 269, signed 2025-07-02)High RiskHemp / Cannabis
Jul 2, 2025
ILHB 1697Joint
Prescription Drug Affordability Act / PBM Reform
Enacted (PA 104-0027)High RiskPBM Reform
Jul 1, 2025
HIHB 302House
Medical Cannabis Qualifying Conditions Expansion
Enacted (Act 241, 2025)Medium RiskHemp / Cannabis
Jul 1, 2025
OHHB 96House
Biennial Budget: Medicaid Pharmacy and Board of Pharmacy
Enacted (Signed Jun 30, 2025)High RiskDrug Distribution
Jun 30, 2025
AZSB 1555Senate
Psilocybin — Conditional Rescheduling
Enacted (Chapter 231)Low RiskControlled Substances
Jun 27, 2025
AZSB 1702Senate
Hemp-Derived Products — Regulation
Died (Adjournment Without Final Passage)High RiskHemp / Cannabis
Jun 27, 2025
NHSB 14Senate
Penalty for Fentanyl Offenses; Mandatory Minimum Sentencing
Passed Senate 2025; carryover (companion SB 467 in 2026)High RiskControlled Substances
Jun 26, 2025
HISB 1245Senate
Pharmacist Reimbursement and Provider Status
Enacted (Act 220, Signed Jun 25, 2025)High RiskScope of Practice
Jun 25, 2025
NHHB 214House
Regulation of Recreational Therapists and Respiratory Care Practitioners; CHRC Delay
Enacted — Chapter 111 (signed Jun 23, 2025)Medium RiskPharmacist Licensure
Jun 25, 2025
NHSB 250Senate
Pharmacist Administration of Long-Acting Injectable Drugs
Enacted (signed Jun 2025)High RiskScope of Practice
Jun 24, 2025
TXSB 3Senate
Relating to the regulation of products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids contained in those products; requiring occupational licenses and permits; imposing fees; creating criminal offenses; authorizing an administrative penalty.
Vetoed by Gov. Abbott 06/22/2025 (after passing Senate 26-5, House 95-44)High RiskHemp / Cannabis
Jun 22, 2025
TXSB 493Senate
Relating to protection of certain disclosures and communications by pharmacists and pharmacies regarding prescription drug benefits.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Medium RiskPBM Reform
Jun 20, 2025
TXHB 3233House
Relating to patient data maintained by pharmacy benefit managers.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Medium RiskPBM Reform
Jun 20, 2025
TXHB 4638House
Relating to the Texas Pharmaceutical Initiative.
Enacted — Signed by Gov. Abbott; effective 09/01/2025High RiskDrug Pricing
Jun 20, 2025
TXHB 46House
Relating to the medical use of low-THC cannabis under and the administration of the Texas Compassionate-Use Program; requiring registration.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Medium RiskHemp / Cannabis
Jun 20, 2025
TXSB 2587Senate
Relating to the access to and use of certain criminal history record information by certain licensing agencies.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Low RiskPharmacist Licensure
Jun 20, 2025
TXSB 1936Senate
Relating to the definition of an abuse unit for certain controlled substances under the Texas Controlled Substances Act.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Medium RiskControlled Substances
Jun 20, 2025
TXSB 20Senate
Relating to the creation of the criminal offense of possession, promotion, or provision of obscene visual material that contains a depiction of a minor created by use of generative artificial intelligence.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Low RiskOmnibus / Technical
Jun 20, 2025
TXSB 1233Senate
Relating to information regarding perinatal palliative care; creating an administrative penalty.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Low RiskPrescription Access
Jun 20, 2025
TXHB 3057House
Relating to health benefit plan coverage for chimeric antigen receptor T-cell therapy.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Medium RiskInsurance / Coverage
Jun 20, 2025
TXSB 670Senate
Relating to patient authorization to access certain investigational sun protection products.
Enacted — Signed by Gov. Abbott; effective immediately (06/20/2025)Low RiskPrescription Access
Jun 20, 2025
TXSB 1833Senate
Relating to the use of a social media platform in furtherance of an offense involving the delivery or distribution of a controlled substance.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Medium RiskControlled Substances
Jun 20, 2025
TXHB 4783House
Relating to a report on governmental opioid antagonist programs to reverse and prevent opioid overdoses.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Low RiskControlled Substances
Jun 20, 2025
TXHB 5155House
Relating to the continuation of the maternal opioid misuse model of care for certain Medicaid recipients.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Low RiskLong-Term Care
Jun 20, 2025
TXHB 3464House
Relating to increasing the criminal penalties for the offenses of providing or possessing a controlled substance.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Medium RiskControlled Substances
Jun 20, 2025
TXSB 269Senate
Relating to required reports of certain vaccine-related or drug-related adverse events.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Medium RiskPharmacy Operations
Jun 20, 2025
TXSB 261Senate
Relating to a prohibition on the offering for sale and the sale of cell-cultured protein.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Low RiskOmnibus / Technical
Jun 20, 2025
NHSB 254Senate
Controlled Substance Inventories; Surrogate Parent CHRC
Enacted (signed Jun 2025)High RiskControlled Substances
Jun 18, 2025
NHSB 285Senate
Renaming "Physician Assistant" to "Physician Associate"
Enacted (signed Jun 2025)Medium RiskScope of Practice
Jun 18, 2025
NHSB 119Senate
Medicaid Pharmaceutical Services and Standing Orders for Ivermectin
Passed Senate Mar 2025; rereferred to committeeHigh RiskPrescription Access
Jun 12, 2025
OKSB 1039Senate
Medical marijuana license; modifying grounds for certain denials; notice; fees
Enacted — Approved by Governor 06/09/2025Low RiskHemp / Cannabis
Jun 11, 2025
TXSB 2308Senate
Relating to the establishment of a consortium to conduct United States Food and Drug Administration-approved clinical trials on the therapeutic use of certain alternative therapies, including ibogaine, for the treatment of certain conditions.
Enacted — Signed by Gov. Abbott; effective immediately (06/11/2025)Medium RiskControlled Substances
Jun 11, 2025
OHSB 209Senate
Jeff, Dave, and Angie Patient Right to Try Act (Senate)
Senate Health CommitteeMedium RiskPrescription Access
Jun 10, 2025
OHSB 210Senate
PBM Licensing and Contract Requirements (Senate Companion)
Senate Health Committee — Superseded by HB 229Medium RiskPBM Reform
Jun 3, 2025
HISB 1429Senate
Medical Cannabis Caregiver Expansion
Enacted (Act 046, Signed 2025)Medium RiskHemp / Cannabis
Jun 1, 2025
ILHR 0334House
Resolution: Eliminate MPJE Exam Requirement
Adopted (Non-Binding)Low RiskPharmacist Licensure
May 31, 2025
HIHB 712House
340B Contract Pharmacy Access Protection
Enacted (Act 143, Signed May 30, 2025) — Upheld in court Feb 2026High Risk340B Program
May 30, 2025
NHHB 73House
Harm Reduction, Substance Misuse, and Governor's Commission on Alcohol and Drug Abuse
Enacted (passed both chambers May 2025)Medium RiskControlled Substances
May 30, 2025
OKHB 1224House
Health care; minor self-consent to health services; granting certain protections to parent or legal guardian related to medical records
Failed — Died in conference 05/30/2025 (House passed; Senate passed 38-7 w/ amendments; SAs rejected)Medium RiskPrescription Access
May 30, 2025
TXSB 1901Senate
Relating to the administration of the Texas Opioid Abatement Fund Council and the Texas Opioid Abatement Trust Fund.
Enacted — Signed by Gov. Abbott; effective immediately (05/30/2025)Low RiskControlled Substances
May 30, 2025
OKHB 2048House
340B Nondiscrimination Act; discriminatory actions; reimbursement; manufacturer; distributor; enforcement
Enacted — Veto overridden 5/29/2025 (Senate 42-3 override)High Risk340B Program
May 29, 2025
OKHB 1808House
Ensuring Transparency in Prescription Drugs Prior Authorization Act
Enacted — Became law without signature 05/29/2025 (Senate 42-0)High RiskInsurance / Coverage
May 29, 2025
OKHB 2298House
Practice of nursing; independent prescriptive authority of Advanced Practice Registered Nurses
Enacted — Filed with Secretary of State 05/29/2025High RiskScope of Practice
May 29, 2025
OKHB 2584House
Physicians assistants; Pharmacy Act; prescriptions for controlled dangerous substances; Physician Assistant Committee
Enacted — Filed with Secretary of State 05/29/2025Medium RiskScope of Practice
May 29, 2025
OKHB 2777House
Opioid Abatement Revolving Fund; appropriations; amounts and source; purpose
Enacted — Became law without signature 05/29/2025Low RiskControlled Substances
May 29, 2025
OKSB 574Senate
Attorney General; broadening approved purposes for opioid grant awards; authorizing certain use of funds
Enacted — Filed with Secretary of State 05/29/2025Low RiskControlled Substances
May 29, 2025
OKSB 773Senate
Pharmacy benefit managers; modifying definitions; prohibiting certain circumstances; AG authority
Vetoed 5/10/2025 — Senate overrode 47-0; House did not override before sine dieHigh RiskPBM Reform
May 29, 2025
OKSB 789Senate
Pharmacy benefit managers; permitting use of certain records without limitations of date or source for certain purposes
Enacted — Became law without signature 05/28/2025High RiskPBM Reform
May 28, 2025
TXHB 879House
Relating to the licensing of certain military veterans as health care providers.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Low RiskPharmacist Licensure
May 28, 2025
HIHB 72House
Registered Pharmacy Technicians — Registration
Enacted (Act 093, Signed May 27, 2025)High RiskPharmacist Licensure
May 27, 2025
OKHB 1810House
Medicaid; modifying, adding, and removing certain prior authorization requirements for contracted entities
Enacted — Became law without signature 05/25/2025Medium RiskInsurance / Coverage
May 27, 2025
TXSB 1236Senate
Relating to the relationship between pharmacists or pharmacies and health benefit plan issuers or pharmacy benefit managers.
Enacted — Signed by Gov. Abbott; effective 09/01/2025 (Senate 31-0, House 142-0)High RiskPBM Reform
May 27, 2025
TXSB 1098Senate
Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or device.
Passed Senate HHS Committee; placed on Senate General State Calendar 05/26/2025 (died on calendar at sine die)Medium RiskDrug Pricing
May 26, 2025
TXSB 1986Senate
Relating to warning labels for opioid prescription drugs.
Placed on Senate General State Calendar 05/26/2025; died on calendar at sine dieMedium RiskPrescription Labeling
May 26, 2025
TXSB 1263Senate
Relating to a pilot program for the safe disposal of prescription drugs, including controlled substances.
Placed on Senate General State Calendar 05/26/2025; died on calendar at sine dieLow RiskPharmacy Operations
May 26, 2025
TXSB 2857Senate
Relating to a prescription drug purchasing pool for certain health benefit plan issuers and employer-sponsored health benefit plans.
Placed on Senate General State Calendar 05/26/2025; died on calendar at sine dieMedium RiskDrug Pricing
May 26, 2025
TXSB 1257Senate
Relating to required health benefit plan coverage for gender transition adverse effects and reversal procedures, treatments, and pharmaceutical products.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Medium RiskInsurance / Coverage
May 24, 2025
TXHB 166House
Relating to committing the criminal offense of endangering a child, elderly individual, or disabled individual by selling, providing, or giving the person a substance containing fentanyl or fentanyl analogs.
Enacted — Signed by Gov. Abbott; effective 09/01/2025Medium RiskControlled Substances
May 24, 2025
NHHB 63House
Relative to the use of nasal spray to treat anaphylaxis
Passed House; Senate Laid on Table (5/22/2025)Low RiskPrescription Access
May 22, 2025
OKSB 993Senate
Pharmacy benefit managers; establishing requirements and limits for certain audit reports and findings
Enacted — Became law without signature 05/22/2025 (Senate 40-0, House 89-0)High RiskPBM Reform
May 22, 2025
OKSB 891Senate
Kratom products; modifying definitions; removing certain packaging and labeling requirements
Enacted — Became law without signature 05/22/2025Low RiskControlled Substances
May 22, 2025
OKSB 518Senate
Medical marijuana packaging; requiring certain warnings on labels
Enacted — Became law without signature 05/21/2025Low RiskHemp / Cannabis
May 21, 2025
AZHB 2175House
Claims — Prior Authorization Medical Director Review
Enacted (Chapter 165)Medium RiskInsurance / Coverage
May 20, 2025
TXSB 1619Senate
Relating to the use of an epinephrine delivery system by certain entities.
Enacted — Signed by Gov. Abbott; effective immediately (05/19/2025)Medium RiskPharmacy Operations
May 19, 2025
TXHB 4014House
Relating to a study on the use of psychedelic therapies in the treatment of certain conditions.
Failed — Referred to HHS 05/19/2025; no further action at sine dieLow RiskControlled Substances
May 19, 2025
TXHB 3540House
Relating to the regulation of pharmacists and the practice of pharmacy, including the administration of vaccines and immunizations by pharmacists and pharmacy interns.
Referred to House Public Health 05/16/2025; failed to advance at sine dieMedium RiskScope of Practice
May 16, 2025
OKSB 906Senate
Practice of pharmacy; establishing certain pharmacy staffing ratio
Enacted — Became law without signature 05/15/2025 (House 81-6)High RiskPharmacy Operations
May 15, 2025
TXHB 5248House
Relating to a pilot program for the safe disposal of prescription drugs, including controlled substances.
Placed on House General State Calendar 05/15/2025; died on calendar at sine dieLow RiskPharmacy Operations
May 15, 2025
GASB 5Senate
Prior Authorization Reduction / Gold Card Program
Enacted — Effective Jul 1, 2025High RiskInsurance / Coverage
May 14, 2025
GASB 276Senate
Medicaid Third-Party Liability — Federal Compliance
Enacted — Effective Jul 1, 2025Medium RiskInsurance / Coverage
May 14, 2025
GAHB 196House
State Health Plan Self-Administered Drug Reimbursement
Enacted — Effective Jul 1, 2025Medium RiskPBM Reform
May 14, 2025
OKHB 1811House
Insurance; chronic conditions; validity period; prior authorization; inpatient; non-inpatient; timeframe
Enacted — Became law without signature 05/14/2025Medium RiskInsurance / Coverage
May 14, 2025
OKSB 391Senate
Opioid overdose fatalities; dissolving Overdose Fatality Review Board; Attorney General oversight
Enacted — Became law without signature 05/14/2025Low RiskControlled Substances
May 14, 2025
OKSB 786Senate
Crimes and punishments; increasing certain fine; prohibiting certain consumption of medical marijuana
Enacted — Became law without signature 05/14/2025Low RiskHemp / Cannabis
May 14, 2025
OHHB 263House
Insulin and Diabetes Device Cost-Sharing Cap
House Health CommitteeMedium RiskDrug Pricing
May 13, 2025
GASB 140Senate
Optometrist Pharmaceutical Dispensing Authority
Enacted — Effective May 13, 2025Medium RiskScope of Practice
May 13, 2025
OKSB 774Senate
Medical marijuana licenses; modifying certain identification number; requiring certain barcode
Enacted — Became law without signature 05/13/2025Low RiskHemp / Cannabis
May 13, 2025
GASB 6Senate
Fentanyl Test Strips — Drug Checking Equipment Authorization
Enacted — Effective Jul 1, 2025Medium RiskControlled Substances
May 12, 2025
GASB 79Senate
Fentanyl Eradication and Removal Act
Enacted — Effective Jul 1, 2025High RiskControlled Substances
May 12, 2025
GASB 72Senate
Hope for Georgia Patients Act — Investigational Drug Access
Enacted — Effective Jul 1, 2025Medium RiskPrescription Access
May 12, 2025
OKSB 398Senate
Uniform Controlled Dangerous Substances Act; modifying administrative procedures for certain order to show cause
Enacted — Became law without signature 05/08/2025 (Emergency clause)Medium RiskControlled Substances
May 12, 2025
OKSB 1066Senate
Medical marijuana; requiring creation and maintenance of certain registry
Enacted — Approved by Governor 05/09/2025Medium RiskHemp / Cannabis
May 12, 2025
OKSB 929Senate
Practice of osteopathic medicine; amending various provisions of the Oklahoma Osteopathic Medicine Act
Enacted — Became law without Governor signature 05/12/2025 (House 84-0)Low RiskScope of Practice
May 12, 2025
OKSB 875Senate
State Medicaid program; making contracted entities ineligible for capitated contracts for failure to meet certain minimum expense requirement
Failed — Vetoed by Governor 05/09/2025 (House 90-0, Senate had passed; no override attempted)High RiskInsurance / Coverage
May 12, 2025
TXHB 1680House
Relating to prior authorization for prescription drug benefits related to the prevention of human immunodeficiency virus infection.
Committee report sent to Calendars 05/12/2025; died on calendar at sine dieMedium RiskInsurance / Coverage
May 12, 2025
TXHB 3317House
Relating to the relationship between pharmacists or pharmacies and health benefit plan issuers or pharmacy benefit managers.
Failed — Laid on the table subject to call 05/12/2025 (House companion to SB 1236 — SB 1236 was the vehicle)Low RiskPBM Reform
May 12, 2025
TXHB 2747House
Relating to requiring certain health care entities to submit notice of material change transactions.
Committee report sent to Calendars 05/10/2025; died on calendar at sine dieMedium RiskPharmacy Operations
May 10, 2025
NHHB 732House
Informed Consent for Psychotropic Drug Prescriptions for Children
Rereferred to committeeMedium RiskPrescription Access
May 8, 2025
TXHB 1027House
Relating to the provision of telepharmacy services.
Failed — Referred to House HHS 05/08/2025; no further action at sine dieMedium RiskPharmacy Operations
May 8, 2025
AZSB 1377Senate
Donated Medicine — Authorized Recipients and Immunity
Enacted (Chapter 139)Low RiskDrug Distribution
May 7, 2025
INSEA 140Joint
Pharmacy Benefit Manager Reform
Enacted (Public Law 189)High RiskPBM Reform
May 6, 2025
INHB 1604House
Copay Accumulator Restrictions
Enacted (Public Law 237)Medium RiskPrescription Access
May 6, 2025
OKHB 1585House
Pharmacy technicians; training guidelines; training skills; on-the-job training; effective date
Enacted — Approved by Governor 05/05/2025 (Senate 43-0; House unanimous)Medium RiskPharmacist Licensure
May 5, 2025
TXHB 3265House
Relating to discriminatory practices by a health benefit plan issuer, pharmacy benefit manager, or pharmacy services administrative organization with respect to certain pharmacies or pharmacists.
Committee report sent to Calendars 05/05/2025; died on calendar at sine dieMedium Risk340B Program
May 5, 2025
AZHB 2405House
Topical Medications — Patient Take-Home
Enacted (Signed 2025)Low RiskPharmacy Operations
May 1, 2025
GAHB 473House
Schedule I Controlled Substances Update (2025)
Enacted — Effective May 1, 2025High RiskControlled Substances
May 1, 2025
GAHB 89House
Pharmacy Records to Maternal Mortality Review Committee
Enacted — Effective Jul 1, 2025Medium RiskPharmacy Operations
May 1, 2025
GAHB 584House
Narcotic Treatment Program Oversight Transfer to DBHDD
Enacted — Effective Jan 1, 2026High RiskControlled Substances
May 1, 2025
TXHB 4051House
Relating to the authority of certain healthcare providers to order and provide or dispense limited quantities of certain medications without a prescription.
Failed — Left pending in committee 04/29/2025Medium RiskScope of Practice
Apr 29, 2025
TXHB 3785House
Relating to labeling requirements for compounded drug products.
Failed — Failed to receive affirmative vote in committee 04/28/2025Medium RiskCompounding / Medical Spas
Apr 28, 2025
TXSB 1868Senate
Relating to adding certain substances to the Texas Controlled Substances Act and regulating kratom and tianeptine.
Failed — Referred to Public Health 04/28/2025; no further action at sine dieMedium RiskControlled Substances
Apr 28, 2025
OHHB 214House
Medicaid/Insurer Prior Authorization Reporting
House Insurance CommitteeLow RiskInsurance / Coverage
Apr 23, 2025
OKHB 1168House
Abortion-inducing drugs; terms; trafficking; felony; exceptions
Engrossed — Passed House; placed on Senate General Order; no Senate floor voteHigh RiskPrescription Access
Apr 23, 2025
OKSB 860Senate
Uniform Controlled Dangerous Substances Act; adding certain substance to Schedule I
Engrossed — Passed Senate; coauthored by Rep. Humphrey in HouseLow RiskControlled Substances
Apr 22, 2025
TXSB 883Senate
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Failed — Referred to Public Health 04/22/2025; no further action at sine dieMedium RiskPrescription Access
Apr 22, 2025
AZHB 2627House
Pharmacies — Emergency Authority
Enacted (Chapter 86)Medium RiskPharmacy Operations
Apr 18, 2025
AZHB 2628House
Pharmacists — Emergency Medication Administration
Enacted (Signed Apr 18, 2025)Medium RiskScope of Practice
Apr 18, 2025
AZSB 1214Senate
Pharmacists — Independent Testing and Treatment
Enacted (Signed Apr 15, 2025)High RiskScope of Practice
Apr 15, 2025
ILHB 1540House
Controlled Substances — Pharmacy ID Requirements
Passed House 108-2-3; Senate AssignmentsLow RiskControlled Substances
Apr 14, 2025
TXSB 1354Senate
Relating to the minimum reimbursement amount for prescription drugs and devices to health benefit plan network pharmacists and pharmacies.
Failed — Co-author authorized 04/14/2025; no further action at sine dieMedium RiskPBM Reform
Apr 14, 2025
ILHB 1159House
Insurance — Pharmacy Benefit Managers (spread pricing, steering, specialty)
House — Rules Committee (last activity 4/10/2025)Medium RiskPBM Reform
Apr 10, 2025
TXSB 1122Senate
Relating to applicability of certain prescription drug insurance laws to health benefit plans and pharmacy benefit managers.
Failed — Not again placed on intent calendar 04/09/2025Medium RiskPBM Reform
Apr 9, 2025
AZHB 2291House
Opioids — Red-Cap Labeling Requirement Repeal
Enacted (Chapter 45)Low RiskControlled Substances
Apr 7, 2025
TXHB 44House
Relating to exceptions to otherwise prohibited abortions based on a physician's reasonable medical judgment.
Failed — Left pending in committee 04/07/2025Medium RiskPrescription Access
Apr 7, 2025
TXSB 2625Senate
Relating to the provision of an abortion-inducing drug.
Failed — Referred to State Affairs 04/03/2025; superseded by HB 7 (2nd Called Session)Medium RiskControlled Substances
Apr 3, 2025
TXSB 1675Senate
Relating to the duties of a pharmacist regarding medication profiles for high-risk patients in long-term care facilities.
Failed — Co-author authorized 03/31/2025; no further action at sine dieMedium RiskLong-Term Care
Mar 31, 2025
GASB 366Senate
Ivermectin OTC (Senate Companion)
Senate Agriculture and Consumer Affairs — Read and Referred (Mar 28, 2025)Low RiskPrescription Access
Mar 28, 2025
OKSB 741Senate
Practice of pharmacy; allowing pharmacist to test for and initiate drug therapy for certain minor, nonchronic health conditions
Failed — Considered and deferred on Senate General Order 3/27/2025Medium RiskScope of Practice
Mar 27, 2025
AZSB 1102Senate
Pharmacy Benefits — Prescribing Exemption
Enacted (Chapter 5)High RiskPBM Reform
Mar 25, 2025
ILHB 3350House
Patient Access 340B Pharmacy
Re-referred to Rules Committee (Rule 19(a))Medium Risk340B Program
Mar 21, 2025
ILHB 3335House
Insurance Code — Weight Loss Drugs
Re-referred to Rules Committee (Rule 19(a))Medium RiskInsurance / Coverage
Mar 21, 2025
TXHB 2978House
Relating to the minimum reimbursement amount for prescription drugs and devices to health benefit plan network pharmacists and pharmacies.
Failed — Referred to Insurance 03/20/2025; no further action at sine dieMedium RiskPBM Reform
Mar 20, 2025
TXSB 1505Senate
Relating to the medical use of low-THC cannabis under and the administration of the Texas Compassionate-Use Program; requiring a license.
Failed — Co-author authorized 03/20/2025; HB 46 was the vehicleLow RiskHemp / Cannabis
Mar 20, 2025
TXHB 3086House
Relating to requirements for pharmaceutical drug manufacturers to report prescription drug costs.
Failed — Referred to Public Health 03/20/2025; no further action at sine dieMedium RiskDrug Pricing
Mar 20, 2025
GAHB 757House
Kratom Product Registration and Compliance Certification
House Agriculture and Consumer Affairs — Second Readers (Mar 18, 2025)Medium RiskControlled Substances
Mar 18, 2025
NHHB 645House
Relative to data collection and reporting requirements of the prescription drug affordability board
Failed — House Tabled (Voice Vote, 3/13/2025); no further actionMedium RiskDrug Pricing
Mar 13, 2025
TXHB 1474House
Relating to the prohibited retail sale and provision to minors of certain over-the-counter weight loss supplements and over-the-counter diet pills.
Failed — Referred to Public Health 03/11/2025; no further action at sine dieLow RiskPharmacy Operations
Mar 11, 2025
TXHB 1319House
Relating to wholesale importation of prescription drugs in this state.
Failed — Referred to Public Health 03/10/2025; no further action at sine dieLow RiskDrug Importation
Mar 10, 2025
NHSB 253Senate
Participation in the Federal 340B Drug Pricing Program
In Senate Health and Human ServicesMedium Risk340B Program
Mar 6, 2025
OKSB 1030Senate
Prescription drug pricing; prohibiting certain action
Introduced — Coauthored by Rep. Deck; held without committee actionHigh RiskDrug Pricing
Mar 5, 2025
TXHB 845House
Relating to the authority of pharmacists to furnish certain medications.
Failed — Referred to Public Health 03/05/2025; no further action at sine dieMedium RiskScope of Practice
Mar 5, 2025
GAHB 690House
PBM Duty of Care to Insureds and Providers
House Insurance — Second Readers (Mar 4, 2025)High RiskPBM Reform
Mar 4, 2025
GASB 314Senate
Wholesale Prescription Drug Importation Act
Senate Health and Human Services — Read and Referred (Mar 3, 2025)High RiskDrug Importation
Mar 3, 2025
GAHB 227House
Putting Georgia's Patients First Act (House Version)
Senate Read and Referred (Feb 28, 2025) — Passed HouseMedium RiskHemp / Cannabis
Feb 28, 2025
OKSB 1064Senate
Health insurance; establishing guidelines for step therapy protocol
Introduced — Placed on Senate General Order; no floor voteMedium RiskInsurance / Coverage
Feb 26, 2025
OKSB 161Senate
Pharmacy benefit management; requiring pharmacy benefit managers to maintain certain fiduciary duty
Introduced — Placed on Senate General Order; no floor voteHigh RiskPBM Reform
Feb 25, 2025
OKHB 1812House
Supervision of Advanced Practice Registered Nurses; definitions; eligibility requirements for physicians; limits; exceptions; responsibilities; disciplinary action; penalties
Introduced — Sen. Jech named principal Senate author; no committee actionMedium RiskScope of Practice
Feb 25, 2025
AZHB 2757House
Essential Drugs — Price Gouging Limits
Died in CommitteeHigh RiskDrug Pricing
Feb 20, 2025
AZHB 2208House
Pharmacists — Below-Cost Reimbursement Prohibition
Died (Stalled after Committee)High RiskPBM Reform
Feb 17, 2025
OKSB 569Senate
Practice of nursing; providing for independent prescriptive authority of Advanced Practice Registered Nurses who meet certain requirements
Introduced — Coauthored by House Speaker Hilbert; held in Senate Health and Human ServicesMedium RiskScope of Practice
Feb 13, 2025
OKSB 1025Senate
Health care; creating the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025; clarifying authority to take certain actions
Introduced — Referred to Senate Business and Insurance (no further action this session)High RiskPBM Reform
Feb 11, 2025
OKSB 252Senate
Medicaid; excluding prescription drug services from certain provisions; directing certain program delivery model
Introduced — Coauthored by Sen. Bergstrom; held without committee actionHigh RiskInsurance / Coverage
Feb 5, 2025
AZSB 1396Senate
Pharmacy Board — Omnibus Modernization
Died (Introduced Dead)Medium RiskOmnibus / Technical
Feb 4, 2025
OKHB 2817House
Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025
Failed — Died in House Rules; did not advanceMedium RiskPBM Reform
Feb 4, 2025
OKHB 1724House
Abortion pills; Prevention of Maternal Harm Act of 2025; coerced abortion; Schedule IV; mifepristone and misoprostol
Failed — Referred to House Criminal Judiciary; no actionMedium RiskControlled Substances
Feb 4, 2025
OKSB 907Senate
Practice of pharmacy; authorizing product fulfillment through central fill pharmacies under certain conditions; authorizing shared services
Introduced — Coauthored by Rep. Stinson; held in Senate Health and Human ServicesMedium RiskPharmacy Operations
Feb 4, 2025
OKSB 771Senate
Advertising; prohibiting certain direct-to-consumer advertising by pharmaceutical companies; creating felony offense
Introduced — Referred to Senate Health and Human Services; no committee actionHigh RiskDrug Distribution
Feb 4, 2025
OKSB 1063Senate
Prescriptions; creating the Oklahoma Health Care Safety Net and Affordable Prescriptions Accessibility Act; prohibiting certain actions; providing for enforcement by Attorney General and Insurance Commissioner
Introduced — Referred to Senate Health and Human ServicesHigh Risk340B Program
Feb 4, 2025
OKSB 665Senate
Freedom of conscience; creating the Medical Ethics Defense Act; granting certain rights and protections to certain medical practitioners, healthcare institutions, or healthcare payers
Introduced — Referred to Senate Health and Human ServicesMedium RiskPrescription Access
Feb 4, 2025
OKSB 27Senate
Controlled dangerous substances; exempting certain practitioners from electronic prescription requirement
Introduced — Coauthored by Rep. Sneed; held without committee actionMedium RiskElectronic Prescribing
Feb 4, 2025
OKHB 1344House
Prescriptions for off-label medications; terms; moral, ethical, or religious exemptions; immunity from liability; good-faith effort; temporary privileges; at-home and outpatient dispensing; disciplinary action; exceptions; World Health Organization
Introduced — Referred to House Rules; no committee actionMedium RiskPrescription Access
Feb 4, 2025
OKHB 2148House
Controlled dangerous substances; terms; pain management clinics; Oklahoma Bureau of Narcotics and Dangerous Drugs Control; exemptions; registration procedures; compliance; suspension; licensed prescriber; designated administrator; operations requirements; infection control; data collection; reporting; written policy; investigation by Bureau; penalties; rules
Introduced — Referred to House Rules; no committee actionMedium RiskControlled Substances
Feb 4, 2025
OKHB 1311House
Controlled dangerous substances; adding chemicals to Schedule I
Introduced — Referred to House Rules; no committee actionLow RiskControlled Substances
Feb 4, 2025
TXSB 398Senate
Relating to the delegation to a pharmacy technician of a pharmacist's authority to administer an immunization or vaccination.
Failed — Referred to HHS 02/03/2025; no further action at sine dieMedium RiskScope of Practice
Feb 3, 2025
GASB 60Senate
PBM Duty of Care (Senate Companion to HB 690)
Senate Insurance and Labor — Read and Referred (Jan 30, 2025)Medium RiskPBM Reform
Jan 30, 2025
GAHB 139House
340B Contract Pharmacy Protection
House Health — Second Readers (Jan 29, 2025)High Risk340B Program
Jan 29, 2025
OHSB 36Senate
Revise the law governing the practice of optometry
Senate — Health Committee (1/29/2025)Medium RiskScope of Practice
Jan 29, 2025
OHHB 12House
Jeff, Dave, and Angie Patient Right to Try Act
House Health CommitteeMedium RiskPrescription Access
Jan 28, 2025
GAHB 100House
Prescription Drug Consumer Financial Protection Act (80% Rebate Passthrough)
House Insurance — Second Readers (Jan 28, 2025)Medium RiskPBM Reform
Jan 28, 2025
NHHB 678House
Prohibiting the sale of over-the-counter weight loss and muscle building supplements to minors
House — Commerce and Consumer Affairs (Public Hearing 1/29/2025)Low RiskPharmacy Operations
Jan 23, 2025
AZHB 2429House
Pharmacy Benefits — Workers' Comp Networks
Died (Never Assigned to Committee)Low RiskPharmacy Operations
Jan 22, 2025